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While neuronal membranes are proposed to be the primary target of amyloid plaques, the effect of
phospholipids on ﬁbril formation kinetics and morphology has not yet been resolved. We report
that interaction of various compositions with neuronal mimics promoted different processes of
ﬁbril formation: negatively charged surfaces increased the lag time and elongation rate in thioﬂavin
T assays, while brain total lipid extract had an opposite effect compared to that in the absence of
lipid. Electron microscopy showed thin and elongated ﬁbrils when the peptide was incubated with
anionic lipids, while neutral surfaces promoted coarse and small ﬁbrils. Circular dichroism and thi-
oﬂavin T assays conﬁrmed an initially unstructured peptide, and measured its transition to an
aggregated beta-sheet conformation.
Structured summary:
Amyloid beta(1–42) binds to Amyloid beta(1–42) by circular dichroism (View interaction)
Amyloid beta(1–42) binds to Amyloid beta(1–42) by ﬂuorescence technology (View interaction)
Amyloid beta(1–42) binds to Amyloid beta(1–42) by electron microscopy (View interaction).
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Alzheimer disease (AD) is of growing concern as the number of
patients contracting the neuro-degenerative ailment is dramati-
cally increasing each year. At present, the most obvious patholog-
ical feature of AD is the plaques of the amyloid-beta (Ab) peptides
found in the brain, or more precisely the aggregated structures de-
rived from their accumulation near neurons [1,2]. The death of
neurons is the major event in AD where neurotoxic aggregates,
i.e., ﬁbrils, have been isolated from various regions of affected
brains [3]. What remains contentious is the oligomeric state in
which the peptides trigger neurotoxic activity [4,5]. The principal
hypothesis is that small soluble oligomers may have more afﬁnity
for neuronal membranes than long ﬁbrils and, by disturbing the
membrane structure, alter the functionality of neurons leading to
their death [6–8]. Several studies have demonstrated a clear inter-chemical Societies. Published by E
D, circular dichroism; Chol,
sialotetrahexosylganglioside;
ue ellipticity; POPC, palmi-
l-phosphatidylethanolamine;
mission electron microscopy;action between amyloid peptides and lipid membranes that have
modiﬁed the peptide structures, ﬁbril formation kinetics and/or
even toxicity [9–15]. It is noteworthy that the lipid systems used
were often a very simplistic mimic of neuronal membranes.
It appears crucial to identify the role of lipids associated with Ab
peptides, in particular if a speciﬁc lipid composition could induce
variation in the aggregation kinetics and ﬁbril formation. The brain
total lipid extract (BTLE) appears to be the closest mimic of neuro-
nal membrane and was ﬁrst investigated. However, only 40% of the
BTLE composition is known. We incorporated these known compo-
nents into model lipid systems; palmitoyloleoyl phosphatidylcho-
line (POPC), palmitoyloleoyl phosphatidylethanolamine (POPE),
palmitoyloleoylphosphatidylserine (POPS), monosialotetrahexo-
sylganglioside (GM1) and cholesterol (Chol) were mixed in propor-
tions that represent a consensus between total brain lipid ratios
and previous studies, to investigate the effect of speciﬁc lipids con-
tained in neuronal membranes. The kinetics of ﬁbril formation
were observed using thioﬂavin T (ThT) assays and ﬁt to extract
the lag phase and the elongation rate; the secondary structure of
the amyloid beta(1–42) (Ab(1–42)) peptide was deconvoluted
from circular dichroism experiments and ﬁbril morphology was
obtained from electron microscopy. The different lipids systems
used to induce Ab(1–42) aggregation showed different kinetic
parameters and ﬁne ﬁbril structures all consistent with beta-sheet
aggregates.lsevier B.V. All rights reserved.
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2.1. Peptide and vesicles preparations
Ab(1–42) (obtained from W.M. Keck Facility, Yale University,
New Haven, USA) stock solution was freshly made prior to all
experiments to ensure the smallest oligomeric form. The desired
amount of peptide was incubated in a 60 mM NaOH solution for
5 min at room temperature. The solution was then diluted ﬁvefold
with MilliQ-water and bath-sonicated for 5 min at room tempera-
ture. When a clear solution was obtained, it was buffered with 10
PBS (pH 7.3, NaCl 140 mM) and spun for 10 min at 15,000g and
4 C in order to remove any remaining aggregates. The peptide
concentration was then measured using UV absorbance at
214 nm with an extinction coefﬁcient deduced from previous ami-
no acid and UV analyses. Over 90% of the expected peptide concen-
tration was obtained at each preparation.
Phospholipids (obtained from Avanti Polar Lipids, Alabaster,
USA) and cholesterol (obtained from Sigma, Castle Hill, Australia)
were used without further puriﬁcation. Each lipid system was pre-
pared by dissolving the desired phospholipids in chloroform/meth-
anol (3:1), the organic solvents were removed using a rotary
evaporator to form a thin ﬁlm before samples were placed under
a high vacuum for 2 h, then hydrated with Milli-Q water (typically
0.5 ml/10 mg lipid) before being lyophilised. The dried samples
were hydrated with PBS buffer to produce a ﬁnal concentration
of 5 mM phospholipid and subjected to three freeze-thaw steps be-
fore being extruded above 30 C through 100 nm polycarbonate
membranes to produce large unilamellar vesicles (LUV).
2.2. ThT assays
ThT (Sigma, Castle Hill, Australia) dye was used to determine
the presence of amyloid-like ﬁbrils. Fluorescence was measured
using a Flexstation 3 (Bio-Strategy Pty Ltd., Hawthorn, Australia)
plate reader. ThT ﬂuorescence was excited at 440 nm and emission
spectra were recorded at 475 nm. 200 ll of 10 lM peptide solution
was prepared containing 20 lM of ThT and 300 lM of appropriate
LUV in a PBS buffer. Six replicates of each system were set in a 96
well plate and properly sealed. Measurements were made each
7 min for 24 h.
The elongation rates and the lag times were extracted from ThT
data using non-linear curve ﬁts. A modiﬁed Richards logistic func-
tion showed the more consistent ﬁt due to an initial slope during
the lag phase and an intensity decrease after the growth ended
[16]:
Y ¼ ðY i þmixÞ þ ðY f þmfxÞ
1þ eðxx0s Þ
ð1Þ
where Y is the ﬂuorescence intensity obtained from ThT measure-
ment; Yi and Yf are the initial and ﬁnal ﬂuorescence intensities,
respectively; mi and mf are the slopes before and after the growth
phase, respectively; x0 is the time to 50% of maximal ﬂuorescence.
2.3. Circular dichroism experiments
Circular dichroism (CD)-spectra (Jasco J-815 spectropolarime-
ter, USA) of peptide solutions were recorded between 200 and
250 nm using a 1 mm path-length quartz cell (Starna, Australia).
An integration time of 8 s at 50 nm/min and a 2 nm slit width were
used. Samples were maintained at 37 C prior to accumulation of 3
scans. The lipid background was subtracted. To estimate the pep-
tide secondary structure content, an analysis of the relevant CD-
spectra was carried out using the CDPro software (http://lamar.col-
state.edu/~ssreeram/CDPro) developed by Woody and coworkers[17,18]. CD values were converted to mean residue ellipticity.
The basis set 7 of the CDPro software was used. Analysis was per-
formed using three methods, CONTIN, CONTIN/LL, and SELCON 3.
In general, CONTIN/LL, a self-consistent method with an incorpo-
rated variable selection procedure, produced the most reliable
results.
2.4. Electron microscopy
After incubation at 37 C with gentle shaking (300 rpm), the
samples were centrifuged at 15,000 rpm for 10 min. 90% of the
supernatant was removed followed by quick vortexing. Carbon-
coated 300-mesh copper grids were glow-discharged in nitrogen
to render the carbon ﬁlm hydrophilic. Each grid was systematically
examined and imaged to reﬂect a representative view of the sam-
ple. A 4 ll aliquot of the sample was pipetted onto each grid. After
30 s adsorption time the excess was drawn off using Whatman 541
ﬁlter paper, followed by staining with 2% aqueous uranyl acetate at
pH 7.2, for 10 s. Grids were air-dried until needed. The samples
were examined using a Tecnai 12 Transmission Electron Micro-
scope (FEI, Eindhoven, The Netherlands) at an operating voltage
of 120 KV. Images were recorded using a Megaview III CCD camera
and AnalySIS camera control software (Olympus, Tokyo, Japan).
3. Results
3.1. Preparation of Ab stock solution
An essential criterion for measuring aggregation kinetics and
thus the effect of phospholipids on Ab(1–42) ﬁbril formation is to
start with a monomeric form of the peptide. Ab(1–42) is well
known to produce variable results due to preformed oligomers act-
ing as seeds [19]. Variations are often observed from batch to batch
or even within a same batch if insufﬁcient precautions are taken. In
the present study, the peptide stock solution was made fresh and
tested using ThT assays and CD measurement to ensure absence
of aggregates. As seen in Fig. 1, the ﬂuorescence signals observed
at the beginning of all experiments, which were not baseline cor-
rected, are similar to each other and to the peptide-free ThT curve
(not shown). Furthermore, the deconvolution of the CD spectra
showed 80% of the peptide being in a random coil conformation
(Fig. 2).
3.2. Effect of lipid matrix on the kinetic of Ab aggregation
Thioﬂavin T is known to bind speciﬁcally to cross-b structures
encountered in Ab(1–42) aggregates [20]. Upon binding, an intensity
increase is observed at 482 nm and was used to assess the aggre-
gation kinetic parameters – the lag phase and the elongation rate
– and change induced by large unilamellar vesicles (LUV) of differ-
ent lipid composition. As seen in Fig. 1, the six replicates of each
system showed fairly consistent reproducibility. The effect of lipid
matrix on the kinetics of Ab(1–42) ﬁbril formation can be directly
compared using the kinetic parameters as seen in Fig. 3 and Table
1. These parameters were extracted from the experimental data by
using a logistic function (1) described by Fink as being only empir-
ical [16]. This approach has been recently criticized by Finke, argu-
ing that a Finke-Watzky 2-step model was more adequate to
describe the nucleation and autocatalytic growth parameters
[21]. However, the binding mode of ThT is not yet satisfactorily de-
scribed, with the probe binding sites still to be identiﬁed [22]. The
unprocessed experimental data obtained in Fig. 1 were not ﬁtted
correctly by the FW 2-step model nor by the commonly used equa-
tion described by Saito et al. [23] while the logistic function (1)
showed satisfactory residual plots and relatively small deviations
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Fig. 1. Time course of: (A) 10 lM Ab(1–42) ﬁbril formation monitored by ThT ﬂuorescence at 37 C, and upon addition of LUVs composed of (B) POPC/Chol, (C) POPC/GM1
(9:1)/Chol, (D) POPC/POPS (4:1)/Chol, (E) POPC/POPE (4:1)/Chol, and (F) BTLE. All experiment done at 30:1 lipid to peptide molar ratio with 20% lipid to cholesterol molar ratio
in PBS buffer. Gentle shaking was performed before each measurement in a 96 well plate. Six duplicates are displayed.
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Fig. 3. 3D plot of kinetics parameters of Ab(1–42) aggregation obtained from ThT
ﬂuorescence curve ﬁtting of 6 duplicate experiments. Projections show the
distribution of the elongation rate (XZ) or the lag time values (YZ).
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Fig. 2. Circular dichroism spectra of: (no symbol) 10 lM Ab(1–42) in PBS buffer or
upon addition of LUVs composed of (circle) POPC/Chol, (square) POPC/POPS (4:1)/
Chol, (triangle) POPC/POPE (4:1)/Chol, and (star) POPC/GM1 (9:1)/Chol. Panel A
fresh sample. Panel B sample incubated at 37 C for 22 h with gentle shaking prior
to measurement. All experiment done at 30:1 lipid to peptide molar ratio with 20%
lipid to cholesterol molar ratio at 37 C in PBS buffer. Three scans were
accumulated.
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crease prior to growth that was observed in all ThT binding curves,
independent of the lipid presence. Also, the ﬁnal intensity of ThT
ﬂuorescence obtained for approximately all samples reached a
similar value but variations were observed between samples afterthe threshold intensity was reached. Indeed, the intensity de-
creased gradually in a system-speciﬁc manner. These features were
not observed in ThT curves by Saito or Fink and may explain the
unsuccessful ﬁt with these equations.
The lipid-free system showed little distribution of the lag phase
and elongation rate across the 6 replicates as observed in the 3D
plot (Fig. 3), centered at 12.2 ± 1.2 h and 0.81 ± 0.06 h1, respec-
tively (Table 1). When 10 lM of Ab(1–42) was incubated with
LUV at a lipid to peptide molar ratio 30:1, dispersal of the kinetic
parameters occurred across the lipid systems used. BTLE provided
the lowest lag time (7.7 ± 2.2 h) but the slowest elongation rate
(0.6 ± 0.12 h1). In contrast, POPC/POPS (4:1 molar ratio) with
20% cholesterol LUV presented the longest lag time (18.7 ± 1.5 h)
Table 1
Kinetic parameters of Ab(1–42) ﬁbril formation.
Lipid systema Lag time (h)e Elongation rate (h1)e
Lipid-free Ab(1–42)b 12.2 ± 1.2 0.81 ± 0.06
POPC/Cholc 15.5 ± 0.7 0.96 ± 0.12
POPC/POPE/Cholc 12.3 ± 1.2 1.10 ± 0.18
POPC/POPS/Cholc 18.7 ± 1.7 0.96 ± 0.18
POPC/GM1/Cholc 10.3 ± 1.5 1.20 ± 0.24
BTLEd 7.7 ± 1.2 0.60 ± 0.12
a Incubated with LUV of 100 nm diameter at a lipid to peptide molar ratio 30:1.
b 10 lM of Ab(1–42) and 20 lM of ThT in all experiments.
c 20% of cholesterol in all experiments.
d According to Avanti, the lipid composition of brain total lipid extract is PC 9.6%,
PE 16.7%, PI 1.6%, PS 10.6%, PA 2.8% and unknown 58.7%.
e Errors are from mean deviation obtained from 6 replicates.
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Fig. 5. Negatively stained transmission electron micrographs of (A) 10 lM Ab(1–42) inc
POPS (4:1)/Chol. All LUV incubated experiments had 30:1 lipid to peptide molar ratio a
752 M.-A. Sani et al. / FEBS Letters 585 (2011) 749–754with slightly faster elongation rate (0.96 ± 0.06 h1) than lipid-free
samples. LUV composed of POPC with 20% cholesterol produced a
slight increase in both Ab(1–42) lag time and elongation rate while
adding 10%mol of ganglioside slightly reduced the lag time to
10.3 ± 1.5 h and, interestingly, promoted the fastest elongation rate
(1.2 ± 0.24 h1). POPC/POPE (4:1 molar ratio) with 20% cholesterol
LUV induced no change in the lag time but increased the elonga-
tion rate to a value similar to that of POPS-containing LUV. Fig. 3
displays a 3D plot showing the distribution of values obtained.
While lipid-free, total brain extract, POPC/Chol and POPC/POPS/
Chol had very reproducible kinetics parameters, POPC/POPE/Chol
and POPC/GM1/Chol produced a broad distribution of elongation
rates and, to a lesser extent, lag time distributions.
3.3. Secondary structure of Ab before and after incubation with
different lipid matrices
The CD spectra of Ab(1–42) before and after incubation with li-
pid LUV are displayed in Fig. 2. The high content of salt (140 mM)
prevented any acquisition below 200 nm due to high signal distor-
tion. All CD spectra prior to incubation displayed typical random
coil lineshapes with minima tending to values below 200 nm.
Deconvolution showed a slightly higher content of beta-sheet in li-
pid-containing sample (30%) than the pure peptide solution (20%)
as displayed in Fig. 4. It is noteworthy that BTLE, unfortunately,
could not be used in CD experiments due to a strong background
signal. After 22 h incubation in a similar condition to ThT assays,
the CD lineshapes underwent a change typical of b-sheet second-
ary structure with a single minima around 218 nm and curves
tending to a maximum below 200 nm. Deconvolution of experi-
mental spectra revealed a signiﬁcant increase in b-sheet popula-
tion up to 70%, as shown in Fig. 4.
3.4. Fibril morphology upon incubation with different lipid matrices
The formation of amyloid ﬁbrils was conﬁrmed by EM, reveal-
ing that the morphology of the aggregates was particular to the li-
pid system. LUV structures prior to and after incubation were
checked by EM and no major change was observed, with all LUVubated with LUVs composed of: (B) BTLE, (C) POPC/GM1 (9:1)/Chol, and (D) POPC/
nd 20% lipid to cholesterol molar ratio in PBS buffer. Scale bars represent 100 nm.
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brils formed without lipids were above 600 nm long, narrow
(10 nm in width) and twisted (periodic dark markings along the
ﬁbrils). Incubation with BTLE produced similar ﬁbrils but with
slightly more twisted and thicker structures (Fig. 5B). Interestingly,
the ﬁbrils seemed to propagate along the LUV surface. POPC/GM1/
Chol (Fig. 5C) and POPC/POPE/Chol (not shown) triggered coarse
and short ﬁbrils. The width and the length of the observed ﬁbrils
varied between 15 and 30 nm and between 200 and 500 nm,
respectively, and fewer contacts with the membrane surface were
observed. The ﬁbrils formed by Ab(1–42) incubated with POPC/
POPS/Chol were narrow, about 8–15 nm wide, and over 600 nm
long with few obvious twisted segments (Fig. 5D).
4. Discussion
While the debate on whether it is small soluble oligomers or
proto-ﬁbrils that are responsible for triggering the destruction of
neurons in AD remains unresolved, the role of the lipid interface
directly exposed and involved in the interaction with the Ab pep-
tides has not been widely investigated. This study shows the
importance of the lipid composition in Ab(1–42) ﬁbril formation.
While the use of a relevant lipid system is crucial to identify a spe-
ciﬁc role of any particular lipid, the composition of neuronal mem-
branes is very heterogeneous and relatively unique according to
the brain region involved [24,25]. The closest available system ap-
peared to be a BTLE but, unfortunately, the exact composition re-
mains unknown, with 40% by mass being phospholipids and
60% made up of unknown species, most likely including ceramides,
gangliosides, cholesterol and free fatty acids [26].
The BTLE showed the more striking effect on Ab(1–42) aggrega-
tion, reducing the lag time and slowing down the elongation rate. A
strong interaction was observed between the peptides and the li-
pid surface, with ﬁbrils adopting long, thin and twisted morphol-
ogy and seen to wrap around the membrane surface. At this
stage, it was not possible to identify the cause of such effects so
precise lipid models were made to elucidate the role of various po-
tential components. The role of the electrostatic interaction was
assessed using negatively charged membranes with 25% POPS,
which signiﬁcantly delayed the formation of ﬁbrils with a faster
rate of elongation and resulted in long and thin aggregates, which
is opposite to what was observed with brain extract. BTLE also con-
tains the anionic PS lipids, though only 10%, thus it is likely that an-
other lipid promoted the differences. POPC/Chol and POPC/POPE/
Chol, which are both neutral membranes, induced an increase in
variation in aggregation kinetics, with the latter having more scat-
ter, possibly related to heterogeneous ﬁbril formation as observed
in Fig. 5. Finally, the effect of 10% GM1 was investigated. Incuba-
tion of Ab(1–42) with GM1-containing LUV did accelerate the
aggregation of the amyloid peptide and alter the morphology of
the ﬁbril. This is supported by recent studies where gangliosides,
even though used in higher amount to produce ‘raft’ domains, pro-
duce similar results [27]. Beside the tendency to form ‘raft’ do-
mains, GM1 are very bulky lipids that can act as crowding agent,
which has been shown to increase the kinetic formation of ﬁbrils
[28].
The complex association between amyloid peptide and
phospholipid has yet to be fully elucidated, but precaution must
be used when model membranes are chosen. Gangliosides are
most likely involved in accelerating ﬁbril formation while electro-
static interactions with phospholipids appeared to slow growth
and produce ﬁner aggregates. Further work is ongoing to reveal
at a molecular level the speciﬁc interaction between phospholipids
and Ab(1–42) and the component(s) of the BTLE that produced the
results obtained in the present study.Acknowledgements
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